FIMECS

Pharmaceutical Manufacturing • Fujisawa City, Kanagawa, Japan • 11-20 Employees

Company overview

Headquarters	村岡東二丁目26番地の1, 藤沢市, 神奈川県 251-0012, JP
Phone number	+812510012
Website	fimecs.com
NAICS	3254
SIC	873
Keywords	Drug Discovery, Oncology, Immuno-Oncology, Targeted Protein Degradation, Bi-Functional Compound, Mid-Size Molecule, Pseudokinase, Undruggable, Protein Degrader
Founded	2018
Employees	11-20
Socials

Key Contacts at FIMECS

Katsuhiro Uto

Chief Executive Officer

Kanae Gamo

Co-Founder & Cso

FIMECS Email Formats

FIMECS uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@fimecs.com), used 54.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@fimecs.com	54.5%
{first initial}.{last name}	j.doe@fimecs.com	45.5%

About FIMECS

FIMECS, Inc. is developing a new class of drugs based on targeted protein degradation for the currently ‘undruggable’ targets in immuno-oncology and oncology areas. The company became able to discover drug candidates for inducing the degradation of disease-relevant targeted proteins by integrating proprietary E3 ligase binders and RaPPIDS™ platform. This drug discovery platform will help providing drugs to the patients all over the world through various internal and collaboration projects.

FIMECS revenue & valuation

Annual revenue	$1,197,770
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$3,900,000
Total funding	$5,100,000